Lost flu sales weigh on Roche and other pharmas in Q1

take their... The absence of last year's windfall profits from drugs and vaccines to tackle the H1N1 swine flu pandemic will be a common theme for several European drugmakers. Roche saw high demand for Tamiflu, a pill used to treat flu, and sales of...